Top View
- Neurobiological Bases of the Use of Atypical Antipsychotics in Treatment-Resistant Major Depressive Disorder
- © 2021 Reachmd Page 1 of 5
- Pharmaabkommen A1 E
- Wo 2009/035473 A2
- Mathew, S.J., Manji, H.K., & Charney, D.S. (2008). Novel Drugs And
- Anti-COVID-19 Compound Library (96-Well)
- Β3-Adrenoceptor As a Novel Treatment Strategy for Depressive Disorders
- O-Ribose Methyltransferase Nsp16 of SARS-Cov-2
- Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence
- Role of Prefrontal Serotonergic and Dopaminergic Systems In
- Elements Toward Novel Therapeutic Targeting of the Adrenergic System Abdelaziz Ghanemi A,B,*, Xintian Hu A,C,**
- Evaluation of the Effects of Desipramine, Venlafaxine And
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- (12) United States Patent (10) Patent No.: US 9,592.288 B2 Schultz Et Al
- Neurological Disease
- Table [1]: Definition of Reported Outcomes Study Outcome
- (12) Patent Application Publication (10) Pub. No.: US 2013/0045979 A1 Sanfilippo (43) Pub
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Elements Toward Novel Therapeutic Targeting of the Adrenergic System
- Drug Repurposing Compound Library (96-Well)
- Confirmation of Antidepressant Potential of the Selective Β3
- WO 2011/012715 Al
- Page Numbers Followed by 'T '
- Adrenergic Receptor Beta Receptor